Role of glycosylation on the ensemble of conformations in the MUC1 immunodominant epitope

被引:2
|
作者
Singh, Jaideep [1 ]
Her, Cheenou [1 ]
Supekar, Nitin [2 ,3 ]
Boons, Geert-Jan [2 ,3 ,4 ,5 ]
Krishnan, Viswanathan V. [1 ,6 ]
Brooks, Cory L. [1 ]
机构
[1] Calif State Univ Fresno, Dept Chem, 2555 E San Ramon Ave, Fresno, CA 93740 USA
[2] Univ Georgia, Dept Chem, 140 Cedar St, Athens, GA 30602 USA
[3] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA USA
[4] Univ Utrecht, Dept Chem Biol & Drug Discovery, Utrecht Inst Pharmaceut Sci, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[5] Univ Utrecht, Bijvoet Ctr Biomol Res, Univ Weg 99, NL-3584 CG Utrecht, Netherlands
[6] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Davis, CA 95616 USA
关键词
antibody-antigen; ensemble; glycobiology; immunotherapy; mucin; NMR; O-GLYCOSYLATION; MONOCLONAL-ANTIBODY; CANCER VACCINES; PHASE-I; PROTEIN; RECOGNITION; PEPTIDE; BINDING; TANDEM; ANTIGEN;
D O I
10.1002/psc.3229
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MUC1 is a membrane glycoprotein, which in adenocarninomas is overexpressed and exhibits truncated O-glycosylation. Overexpression and altered glycosylation make MUC1 into a candidate for immunotherapy. Monoclonal antibodies directed against MUC1 frequently bind an immunodominant epitope that contains a single site for O-glycosylation. Glycosylation with tumor carbohydrate antigens such as the Tn-antigen (GalNAc-O-Ser/Thr) results in antibodies binding with higher affinity. One proposed model to explain the enhanced affinity of antibodies for the glycosylated antigen is that the addition of a carbohydrate alters the conformational properties, favoring a binding-competent state. The conformational effects associated with Tn glycosylation of the MUC1 antigen was investigated using solution-state NMR and molecular dynamics. NMR experiments revealed distinct substructures of the glycosylated MUC1 peptides compared with the unglycosylated peptide. Molecular dynamics simulations of the MUC1 glycopeptide and peptide revealed distinguishing differences in their conformational preferences. Furthermore, the glycopeptide displayed a smaller conformational sampling compared with the peptide, suggesting that the glycopeptide sampled a narrower conformational space and is less dynamic. A comparison of the computed ensemble of conformations assuming random distribution, NMR models, and molecular dynamics simulations indicated that the MUC1 glycopeptide and aglycosylated peptide sampled structurally distinctly ensembles and that these ensembles were different from that of the random coil. Together, these data support the hypothesis that that conformational pre-selection could be an essential feature of these peptides that dictates the binding affinities to MUC1 specific antibodies.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] The multifaceted role of MUC1 in tumor therapy resistance
    Weiqiu Jin
    Mengwei Zhang
    Changzi Dong
    Lei Huang
    Qingquan Luo
    Clinical and Experimental Medicine, 2023, 23 : 1441 - 1474
  • [42] The multifaceted role of MUC1 in tumor therapy resistance
    Jin, Weiqiu
    Zhang, Mengwei
    Dong, Changzi
    Huang, Lei
    Luo, Qingquan
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1441 - 1474
  • [43] MUC1 is an oncoprotein with a significant role in apoptosis (Review)
    Supruniuk, Katarzyna
    Radziejewska, Iwona
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 59 (03)
  • [44] Essential role of MUC1 in T cell activation
    Mukherjee, P
    Ginardi, AR
    Tinder, TL
    Gendler, SJ
    FASEB JOURNAL, 2002, 16 (04): : A697 - A697
  • [45] The Role of MUC1 Splice Variants in Cellular Inflammation
    Imbert, Yoannis
    Klinge, Carolyn M.
    FASEB JOURNAL, 2010, 24
  • [46] MUC1 immunotherapy
    Beatson, Richard E.
    Taylor-Papadimitriou, Joyce
    Burchell, Joy M.
    IMMUNOTHERAPY, 2010, 2 (03) : 305 - 327
  • [47] RUNNING A MUC1
    McCarthy, Nicola
    NATURE REVIEWS CANCER, 2012, 12 (05) : 317 - 317
  • [48] The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer
    Duncan T.J.
    Watson N.F.S.
    Al-Attar A.H.
    Scholefield J.H.
    Durrant L.G.
    World Journal of Surgical Oncology, 5 (1)
  • [49] Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model
    Rowse, GJ
    Tempero, RM
    VanLith, ML
    Hollingsworth, MA
    Gendler, SJ
    CANCER RESEARCH, 1998, 58 (02) : 315 - 321
  • [50] Mimic 1 of MUC1
    Finn, OJ
    Gendler, SJ
    NATURE BIOTECHNOLOGY, 1998, 16 (03) : 236 - 237